The most commonly supported theory about the role of UCP2 in cancer cell proliferation and chemoresistance has been linked to its ability to reduce ROS levels by lowering the electrochemical gradient across the IMM thanks to its possible protonophoric activity. This evidence concerns the gene UCP2 and cancer.